AIDS Breakthrough? Study Reveals New Info on HIV Drugs

Preliminary results from a cross-country study suggests that antiretroviral drugs, used to treat HIV patients, have the added benefit of making the disease far less infectious. Suggested Reading The Root 100 – 2020 Black History Month – 2022 Hip-Hop 50 Year – 2023 Video will return here when scrolled back into view Stefon Diggs and…

Preliminary results from a cross-country study suggests that antiretroviral drugs, used to treat HIV patients, have the added benefit of making the disease far less infectious.

Video will return here when scrolled back into view
Stefon Diggs and Cardi B Viral Boat Video Prompts Response from Patriots Coach
Stefon Diggs and Cardi B Viral Boat Video Prompts Response from Patriots Coach

The study, which followed nearly 2,000 couples (each couple was made up of one person who had HIV and one who didn't),ย  according to the Wall Street Journal "confirms a growing body of less rigorous research and is likely to inject new urgency into treatment campaigns, especially in Africa, home to two thirds of the more than 33 million people estimated to have HIV world-wide." The results should breathe new life into treatment campaigns and perhaps bring an end to a disagreement within the "AIDS world" over how much money to allocate to antiretroviral drugs. As of 2009, while 5 million people took the (very expensive) drugs, 10 million more needed them.

Despite the promising news, the same safe-sex measures we've always been taught should be taken. And researchers warn that 97 percent of the couples in the study were heterosexual, and the new findings don't necessarly apply to gay couples. Nevertheless, in this decades-long fight to squash this awful epidemic, news like this is always good.

Read more at the Wall Street Journal.

In other news: Bishop Eddie Long: Judge Says Settlement Unlikely.

Like ย The Root on Facebook. Follow us on Twitter.

Lauren is a former Deputy Editor of The Root.

Straight From The Root

Sign up for our free daily newsletter.